CLINICAL IMPLEMENTATION OF A NOVEL HIGH-THROUGHPUT SCREEN OF PRIMARY LEUKEMIA CELLS TO PERSONALIZE THERAPY FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

被引：0
|
作者：
Frattini, M. [1 ]
Shum, D. [1 ]
Heaney, M. [1 ]
Brentjens, R. [1 ]
Maslak, P. [1 ]
Jurcic, J. [1 ]
Djaballah, H. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0048
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [31] OUTCOMES OF SALVAGE CHEMOTHERAPY REGIMENS IN CHILDREN AND ADOLESCENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
    Tak, Himangi
    Trivedi, Maharshi
    Joshi, Nitin
    Panchal, Harsha
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S553 - S553
  • [32] Mito-FLAG as salvage therapy for relapsed and refractory acute myeloid leukemia
    Hänel, M
    Friedrichsen, K
    Hänel, A
    Herbst, R
    Morgner, A
    Neser, S
    Nicklisch, M
    Teich, M
    Ehninger, G
    Fiedler, F
    ONKOLOGIE, 2001, 24 (04): : 356 - 360
  • [33] FLAG salvage therapy combined with idarubicin in relapsed/refractory acute myeloid leukemia
    Westhus, Jonas
    Noppeney, Richard
    Duehrsen, Ulrich
    Hanoun, Maher
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1014 - 1022
  • [34] Time-sequential chemotherapy as treatment for refractory or relapsed adult acute myeloid leukemia (AML).
    Martino, R
    Altés, A
    Guárdia, R
    Sureda, A
    Brunet, S
    Briones, J
    Sierra, J
    BLOOD, 1998, 92 (10) : 217B - 217B
  • [35] Patterns of failure for refractory or relapsed acute myeloid leukemia (AML) displaying a normal karyotype.
    Thomas, X
    Chelghoum, Y
    Le, QH
    Revesz, D
    Elhamri, M
    Troncy, J
    Michallet, M
    BLOOD, 2003, 102 (11) : 248B - 248B
  • [36] HIGH- THROUGHPUT SCREEN ON PRIMARY HUMAN ACUTE MYELOID LEUKEMIA STEM CELLS (LSCS) IDENTIFIES NOVEL ANTI-LSC COMPOUNDS
    Iasenza, Isabella
    Safa, Safia
    Barabe, Frederic
    Cellot, Sonia
    Wilhelm, Brian
    Eppert, Kolja
    EXPERIMENTAL HEMATOLOGY, 2022, 111 : S95 - S95
  • [37] A Phase 1 Trial of Valemetostat in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
    Erba, Harry P.
    Oluwole, Olalekan O.
    Bixby, Dale
    Rampal, Raajit K.
    Fathi, Amir T.
    Paliwal, Prashni
    Jin, Jin
    Inoue, Ai
    Daver, Naval
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S311 - S312
  • [38] High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia
    Loriaux, Marc
    Levine, Ross
    Tyner, Jeffrey
    Frohling, Stephan
    Scholl, Claudia
    Stoffregen, Eric
    Wernig, Gerlinde
    Erickson, Heidi
    Eide, Chris
    Berger, Roland
    Bernard, Oliver
    Griffin, James
    Stone, Richard
    Meyerson, Matthew
    Heinrich, Michael
    Deininger, Michael
    Gilliland, Gary
    Druker, Brian
    BLOOD, 2007, 110 (11) : 271A - 271A
  • [39] Multiplex high-throughput gene mutation analysis in acute myeloid leukemia
    Dunlap, Jennifer
    Beadling, Carol
    Warrick, Andrea
    Neff, Tanaya
    Fleming, William H.
    Loriaux, Marc
    Heinrich, Michael C.
    Kovacsovics, Tibor
    Kelemen, Katalin
    Leeborg, Nicky
    Gatter, Ken
    Braziel, Rita M.
    Press, Richard
    Corless, Christopher L.
    Fan, Guang
    HUMAN PATHOLOGY, 2012, 43 (12) : 2167 - 2176
  • [40] High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia
    Loriaux, Marc M.
    Levine, Ross L.
    Tyner, Jeffrey W.
    Froehling, Stefan
    Scholl, Claudia
    Stoffregen, Eric P.
    Wernig, Gerlinde
    Erickson, Heidi
    Eide, Christopher A.
    Berger, Roland
    Bernard, Olivier A.
    Griffin, James D.
    Stone, Richard M.
    Lee, Benjamin
    Meyerson, Matthew
    Heinrich, Michael C.
    Deininger, Michael W.
    Gilliland, D. Gary
    Druker, Brian J.
    BLOOD, 2008, 111 (09) : 4788 - 4796
12345